We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cancer Research UK Identifies Novel Role for CD169+ Macrophages in Activating Invariant Natural Killer T Cells

Product News   Feb 09, 2011

 
Cancer Research UK Identifies Novel Role for CD169+ Macrophages in Activating Invariant Natural Killer T Cells
FURTHER INFORMATION
 
 
 

Related Product News

Extensive CAR-T Cell Range for Research & Immunotherapy

Product News

AMSBIO announce new, best-in-class CAR-T cells, engineered CAR-T target cells, PBMC, cell media and activation beads in response to the rapid growth in research on the therapeutic uses of CAR-T cells.

READ MORE

IDT and Washington University Join Forces to Increase Access to the Latest NGS Technologies

Product News

Preferred provider program pools expertise to deliver highest-quality sequencing data, even for challenging projects.

READ MORE

Merck Introduces New Integrated Plug & Play Upstream Development Service

Product News

Adaptive approach to cell line development, analytics and clone selection for emerging biotechs and start-ups.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE